RE: Generic24 Aug 2018 14:18
Leister totally agree, this is a side show for N4 reformulated version of viagra. Nuvec is what we will measure the N4 success story, as per last RNS we are waiting for all the results of sidenafil before the final decision. The sp has already discounted the delay, even with the positive update of Nuvec. Having accounted for the last bismal RNS any positive update will rerate us back to june's valuation IMO under £7 million is a joke